ERICKA GREEN: Open Payments
NPI 1275110900 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,352 in 65 payments from 12 companies in 2025. Trend: 2023 $590 · 2024 $642 · 2025 $1,352
Food & beverage: $1,352
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $284 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $259 |
| ABBVIE INC. | 9 | $234 |
| Vanda Pharmaceuticals Inc. | 12 | $158 |
| Janssen Pharmaceuticals, Inc | 2 | $140 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Gilead Sciences, Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $38 |
| Braeburn Inc. | 1 | $21 |
Products named: Auvelity, CAPLYTA, VRAYLAR, FANAPT, INVEGA SUSTENNA, REXULTI, COBENFY, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
